Skip to main content
Protagonist Therapeutics, Inc logo

Protagonist Therapeutics, Inc — Investor Relations & Filings

Ticker · PTGX ISIN · US74366E1029 US Manufacturing
Filings indexed 641 across all filing types
Latest filing 2026-05-05 Interim / Quarterly Rep…
Country US United States of America
Listing US PTGX

About Protagonist Therapeutics, Inc

https://www.protagonist-inc.com/

Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company that specializes in the discovery and development of peptide-based new chemical entities. The company utilizes its proprietary technology platform to engineer novel oral and injectable peptide therapeutics. Its development pipeline is focused on creating treatments for rare and prevalent diseases, particularly in the areas of hematology and gastroenterology, addressing significant unmet medical needs.

Recent filings

Filing Released Lang Actions
10-Q - Protagonist Therapeutics, Inc (0001377121) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-05 English
DEF 14A - Protagonist Therapeutics, Inc (0001377121) (Filer)
Proxy Solicitation & Information Statement
2026-04-28 English
4 - Protagonist Therapeutics, Inc (0001377121) (Issuer)
Director's Dealing
2026-03-28 English
4 - Protagonist Therapeutics, Inc (0001377121) (Issuer)
Director's Dealing
2026-03-28 English
4 - Protagonist Therapeutics, Inc (0001377121) (Issuer)
Director's Dealing
2026-03-28 English
SCHEDULE 13G/A - Protagonist Therapeutics, Inc (0001377121) (Subject)
Major Shareholding Notification
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.